United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

viatris uk healthcare ltd - atorvastatin calcium trihydrate - chewable tablet - 10mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

viatris uk healthcare ltd - atorvastatin calcium trihydrate - chewable tablet - 20mg

Israel - English - Ministry of Health

intervet ( israel) ltd - fluralaner - chewable tablets - fluralaner 1000 mg - dogs: for the treatment of tick and flea infestations in dogs. this veterinary medicinal product is a systemic insecticide and acaricide that provides:- immediate and presistent flea (ctenocephalides felis) killing activity for 12 weeks,- immediate and persistent tick killing activity for 12 weeks for ixodes ricinus, dermacentor reticulatus and d. variabilis,- immediate and presistent tick killing activity for 8 weeks for rhipicephalus sanguineus.fleas and ticks must attach to the host and commence feeding in order to be exposed to the active substance. the onset of effect is within 8 hours of attachment for fleas (c. felis) and 12 hours of attachment for ticks (i. ricinus). the product can be used as part of a treatment strategy for the control of flea allergy dermatitis (fad).for the treatment of demodicosis caused by demodex canis.for the treatment of sarcoptic mange (sarcoptes scabiei var. canis) infestation.

Israel - English - Ministry of Health

intervet ( israel) ltd - fluralaner - chewable tablets - fluralaner 112.5 mg - dogs: for the treatment of tick and flea infestations in dogs. this veterinary medicinal product is a systemic insecticide and acaricide that provides:- immediate and presistent flea (ctenocephalides felis) killing activity for 12 weeks,- immediate and persistent tick killing activity for 12 weeks for ixodes ricinus, dermacentor reticulatus and d. variabilis,- immediate and presistent tick killing activity for 8 weeks for rhipicephalus sanguineus.fleas and ticks must attach to the host and commence feeding in order to be exposed to the active substance. the onset of effect is within 8 hours of attachment for fleas (c. felis) and 12 hours of attachment for ticks (i. ricinus). the product can be used as part of a treatment strategy for the control of flea allergy dermatitis (fad).for the treatment of demodicosis caused by demodex canis.for the treatment of sarcoptic mange (sarcoptes scabiei var. canis) infestation.

Israel - English - Ministry of Health

intervet ( israel) ltd - fluralaner - chewable tablets - fluralaner 1400 mg - dogs: for the treatment of tick and flea infestations in dogs. this veterinary medicinal product is a systemic insecticide and acaricide that provides:- immediate and presistent flea (ctenocephalides felis) killing activity for 12 weeks,- immediate and persistent tick killing activity for 12 weeks for ixodes ricinus, dermacentor reticulatus and d. variabilis,- immediate and presistent tick killing activity for 8 weeks for rhipicephalus sanguineus.fleas and ticks must attach to the host and commence feeding in order to be exposed to the active substance. the onset of effect is within 8 hours of attachment for fleas (c. felis) and 12 hours of attachment for ticks (i. ricinus). the product can be used as part of a treatment strategy for the control of flea allergy dermatitis (fad).for the treatment of demodicosis caused by demodex canis.for the treatment of sarcoptic mange (sarcoptes scabiei var. canis) infestation.

Israel - English - Ministry of Health

intervet ( israel) ltd - fluralaner - chewable tablets - fluralaner 250 mg - dogs: for the treatment of tick and flea infestations in dogs. this veterinary medicinal product is a systemic insecticide and acaricide that provides:- immediate and presistent flea (ctenocephalides felis) killing activity for 12 weeks,- immediate and persistent tick killing activity for 12 weeks for ixodes ricinus, dermacentor reticulatus and d. variabilis,- immediate and presistent tick killing activity for 8 weeks for rhipicephalus sanguineus.fleas and ticks must attach to the host and commence feeding in order to be exposed to the active substance. the onset of effect is within 8 hours of attachment for fleas (c. felis) and 12 hours of attachment for ticks (i. ricinus). the product can be used as part of a treatment strategy for the control of flea allergy dermatitis (fad).for the treatment of demodicosis caused by demodex canis.for the treatment of sarcoptic mange (sarcoptes scabiei var. canis) infestation.

Israel - English - Ministry of Health

intervet ( israel) ltd - fluralaner - chewable tablets - fluralaner 500 mg - dogs: for the treatment of tick and flea infestations in dogs. this veterinary medicinal product is a systemic insecticide and acaricide that provides:- immediate and presistent flea (ctenocephalides felis) killing activity for 12 weeks,- immediate and persistent tick killing activity for 12 weeks for ixodes ricinus, dermacentor reticulatus and d. variabilis,- immediate and presistent tick killing activity for 8 weeks for rhipicephalus sanguineus.fleas and ticks must attach to the host and commence feeding in order to be exposed to the active substance. the onset of effect is within 8 hours of attachment for fleas (c. felis) and 12 hours of attachment for ticks (i. ricinus). the product can be used as part of a treatment strategy for the control of flea allergy dermatitis (fad).for the treatment of demodicosis caused by demodex canis.for the treatment of sarcoptic mange (sarcoptes scabiei var. canis) infestation.

Israel - English - Ministry of Health

pharma shalom - aluminium oxide hydrated; dimethicone; magnesium hydroxide - chewable tablets - magnesium hydroxide 200 mg; dimethicone 25 mg; aluminium oxide hydrated 200 mg - combinations - antacid, antiflatulent, relief of sensation of heartburn.

Israel - English - Ministry of Health

dexcel ltd, israel - lamotrigine - dispersible/chewable tablets - lamotrigine 5 mg - lamotrigine - lamotrigine - epilepsy • adults and adolescents aged 13 years and above: - adjunctive or monotherapy treatment of partial seizures and generalised seizures, including tonic-clonic seizures. - seizures associated with lennox-gastaut syndrome. lamodex is given as adjunctive therapy but may be the initial antiepileptic drug (aed) to start with in lennox-gastaut syndrome. • children and adolescents aged 2 to 12 years: - adjunctive treatment of partial seizures and generalised seizures, including tonic-clonic seizures and the seizures associated with lennox-gastaut syndrome. - monotherapy of typical absence seizures.

Israel - English - Ministry of Health

dexcel ltd, israel - lamotrigine - dispersible/chewable tablets - lamotrigine 25 mg - lamotrigine - lamotrigine - epilepsy • adults and adolescents aged 13 years and above: - adjunctive or monotherapy treatment of partial seizures and generalised seizures, including tonic-clonic seizures. - seizures associated with lennox-gastaut syndrome. lamodex is given as adjunctive therapy but may be the initial antiepileptic drug (aed) to start with in lennox-gastaut syndrome. • children and adolescents aged 2 to 12 years: - adjunctive treatment of partial seizures and generalised seizures, including tonic-clonic seizures and the seizures associated with lennox-gastaut syndrome. - monotherapy of typical absence seizures.bipolar disorder • adults aged 18 years and above - prevention of depressive episodes in patients with bipolar i disorder who experience predominantly depressive episodes.lamodex is not indicated for the acute treatment of manic or depressive episodes.